Why the study?
Visual estimation of pupil size is used to grade opioid withdrawal severity, but few studies have evaluated the clinical utility of precise automated pupillometry measurements.
Does automated pupillometry detect changes in pupil size following opioid agonist therapy in hospitalized patients with opioid use disorder?
Does automated pupillometry detect changes in pupil size following opioid agonist therapy in hospitalized patients with opioid use disorder?
Automated pupillometry can detect small but significant changes in pupil size within 15 minutes of opioid agonist therapy dosing, which correlates with low withdrawal scores.
Answers are grounded in this paper and cite their sources.
May support pupillometry for early opioid effect monitoring in OUD inpatients; hypothesis-generating, requires prospective validation.
Introduction/Background: A rough, visual estimate of pupil size is used in grading the severity of opioid withdrawal. Few studies have examined the clinical utility of more precise automated pupillometry measurements. Methods: This prospective cohort study enrolled 27 patients receiving opioid agonist therapy (OAT) to treat cravings or withdrawal during an acute hospitalization. Six sets of automated pupillometry measurements were obtained at regular intervals before and after administration of OAT. Clinical Opiate Withdrawal Scale measurements were performed pre and post OAT. Primary outcomes included pupil size in dark and bright illumination (mm). Latency of the pupillary light response (s), constriction and dilation velocity (mm/s), and percent constriction (%) were secondary outcomes. Results: The mean predosing pupil size in dark and bright illumination was 4.33 ± 1.40 mm and 2.96 ± 0.79 mm, respectively. A significantly decreased mean pupil size was first detected at 15 minutes postdosing (4.01 ± 1.34 mm, P = 0.0115 for dark illumination; 2.71 ± 0.72 mm, P = 0.0003 for bright illumination) and this reduction in pupil size persisted at later postdosing timepoints. Those with Clinical Opiate Withdrawal Scale <5 after dosing had a greater decrease in dark pupil size (10.6% ± 13.2 vs 3.2% ± 3.2, P = 0.043). There was no significant change in the remaining pupil reactivity parameters. Conclusions: Automated pupillometry demonstrated a small but significant change in mean pupil size that occurred within 15 minutes of OAT dosing and was associated with low withdrawal scores. This pilot may inform future work to incorporate pupillometry measurement into OAT dosing assessments.
No takes yet. Share an insight, caveat, or question.
Peeler et al. (2020) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: